Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients

Clinical trial NCT02744209 · TERMINATED

Trial details

NCT number: NCT02744209
Sponsor: Mayo Clinic
Status: TERMINATED
Study type: OBSERVATIONAL

Stage IV Melanoma

Start date: 2016-04-01
Primary completion: 2019-01-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.